C

Cardinal Health

Distributes medicines and medical supplies

Vice President - Strategy & Business Development, Biopharma Solutions

Full-TimeDeadline 10/9/26
$166.3k - $281.3k+ Bonus eligible
Expert
Bachelor's, Master's
Dublin, OH, USA+1 moreMore locations: United States
RemoteHeadquarters in Dublin, Ohio is highly preferred; relocation support is available. Travel expectation is 10%.
Business & StrategyCorporate Strategy
Company Does Not Provide H1B Sponsorship

About the job

Requirements
  • A bachelor's degree in Business is required.
  • Experience in Biopharma Services, such as patient access HUB services, real-world data/evidence, third-party logistics, or related biopharma service offerings, or in related functions within pharmaceutical manufacturers.
  • A strong understanding of how purchasing decisions are made for HUB services, real-world evidence, third-party logistics, and related biopharma service offerings.
  • A strong understanding of strategic thinking, business acumen, and analytical methods.
  • Demonstrated familiarity with the strategic landscape and competitive environment for specialty pharmaceuticals and related healthcare services.
  • The ability to develop actionable, high-value strategies.
  • The ability to leverage resources and capabilities across teams.
  • The ability to influence leaders and serve as a trusted advisor with integrity.
  • Verbal and written communication skills, with the ability to adapt communication for varying audiences.
  • Innovation and an entrepreneurial spirit.
  • Strong financial acumen and business savvy.
  • Individual motivation.
Responsibilities
  • Lead strategy development for the Specialty businesses serving pharmaceutical manufacturers and specialty community-based provider offices, and create linkages across business strategies where appropriate.
  • Develop and prepare high-quality content to support strategic recommendations.
  • Anticipate and build alignment around changes in the industry landscape.
  • Determine strategic direction by identifying gaps in the existing portfolio and capabilities to scale.
  • Lead or assist with all phases of business cases, including market analysis, value proposition, strategic fit, economic models, and launch, to support new initiatives.
  • Prospect for, develop, and maintain a pipeline of strategic opportunities.
  • Drive business-unit merger and acquisition processes with Corporate Development, and remain involved after integration to help acquisitions become sustainable.
  • Serve as a trusted advisor to leaders across the Specialty businesses and collaborate with them to develop strategic direction and objectives.
  • Lead the Strategy and Business Development team, including hiring, coaching, developing, and managing team members, and fostering accountability, growth, and high performance.
Desired Qualifications
  • A master's degree in business or a related area is strongly preferred.
  • A minimum of 10 years of experience in strategy roles is preferred.
  • Prior healthcare provider-side experience is preferred.
  • Prior consulting experience within healthcare, life sciences, or pharmaceutical manufacturers is preferred.
  • Mergers and acquisitions and/or partnership development experience is preferred.

About the company

Cardinal Health distributes pharmaceuticals and medical products to pharmacies, hospitals, clinics and physician offices, mainly in the United States. Its largest business buys branded, generic and specialty medicines from drugmakers and delivers them to retail chains, independent pharmacies and health systems. The company also makes and sources Cardinal Health brand medical and surgical supplies, runs nuclear pharmacies that prepare radioactive drugs for imaging, and ships home-health supplies directly to patients. It earns most of its revenue from the margin on products it distributes, plus manufacturing, logistics and services for specialty physician practices. Cardinal Health was founded in 1971 and is based in Dublin, Ohio.

Company Size

10,001+

Company Stage

N/A

Total Funding

$270.6M

Headquarters

Dublin, California

Founded

1971

Get referred to Cardinal Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Equity has momentum: in August 2026, Cardinal guided fiscal 2027 EPS growth of 13% to 15%, above its long-term target.
  • Specialty drugs drive profit: brand and specialty medicines lifted pharma segment profit 23% in the year ending June 2026.
  • Cardinal keeps raising its payout: in May 2026, its board lifted the quarterly dividend to $0.5158 per share from $0.5107.

What critics are saying

  • One buyer dominates: CVS Health supplied 28% of Cardinal's fiscal 2026 revenue, and the five largest customers 43%.
  • Opioid bills continue: Cardinal held $4.3 billion for national settlements in June 2026 and paid $374 million in July.
  • Factory jobs are going: Cardinal subsidiary KPR filed in March 2026 to close its Augusta, Georgia plant, cutting 213 jobs.

What makes Cardinal Health unique

  • Cardinal owns specialist doctor networks: its management companies support about 3,000 gastroenterology, urology and other providers in 32 states.
  • Cardinal makes products as well as moving them: its own-brand medical and surgical supplies drive growth in its supplies segment.
  • Cardinal runs nuclear pharmacies: its Nuclear and Precision Health unit prepares radioactive drugs used in medical imaging.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Paid Vacation
  • Health Savings Account/Flexible Spending Account
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Short- and Long-term Disability Coverage
  • Paid Parental Leave
  • Wellness Program

Company News

Yahoo Finance
Aug 11th, 2026
Cardinal Health forecasts profit above estimates on specialty drug demand, eyes $1B buyback

Cardinal Health forecast fiscal 2027 profit between $12.40 and $12.60 per share, exceeding analyst expectations of $12.04, driven by strong demand for specialty drugs. The US drug distributor's shares rose over 4% in premarket trading. The company's fourth-quarter adjusted profit of $2.91 per share beat estimates of $2.42. However, total revenue of $63.67 billion missed expectations of $65.03 billion. Cardinal Health is benefiting from rising demand for biosimilars and high-margin medicines treating cancer, rheumatoid arthritis, and autoimmune diseases. Its Pharmaceutical and Specialty Solutions unit saw sales increase 6% to $55.4 billion. Last month, Cardinal purchased AdaptHealth's diabetes business and Strive Medical for approximately $360 million combined. The company also announced $1 billion in planned share repurchases for fiscal 2027.

Healthcare Dive
Jul 21st, 2026
Cardinal Health acquires Strive Medical and AdaptHealth's diabetes unit for $360M to expand home care services

Cardinal Health has agreed to acquire multi-specialty supply company Strive Medical and AdaptHealth's diabetes business for a combined $360 million in cash. The drug distributor said the acquisitions will expand its at-home solutions business, which delivers medical supplies directly to patients. The deals build on Cardinal's recent investments in home care services. The company's at-home unit generated $1.7 billion in revenue during its third quarter this year, helping grow profit by 34% year over year. Cardinal expects the acquisitions to be earnings accretive within a year of closing. AdaptHealth's diabetes unit serves over 225,000 patients annually, primarily delivering continuous glucose monitors. Strive serves more than 20,000 customers yearly, specialising in urology, wound care and incontinence supplies.

PR Newswire
Jan 31st, 2024
Cardinal Health To Acquire Specialty Networks And Its Pps Analytics Platform, A Technology Enabled Multi-Specialty Group Purchasing And Practice Enhancement Organization In Urology, Rheumatology And Gastroenterology

Transaction creates increased clinical and economic value for 11,500 specialty providers, including more than 7,000 physicians across 1,200 independent physician practices. Transaction creates platform for Cardinal Health expansion across specialty therapeutic areas. Transaction enhances capabilities of Cardinal Health Specialty and supports ongoing build of Navista™ NetworkDUBLIN, Ohio, Jan. 31, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that it has entered into a definitive agreement to acquire Specialty Networks, a technology-enabled multi-specialty group purchasing and practice enhancement organization for $1.2B in cash. Specialty Networks creates clinical and economic value for independent specialty providers and partners across multiple specialty GPOs: UroGPO, Gastrologix and GastroGPO, and United Rheumatology

Intelligence360 News
Mar 7th, 2023
Cardinal Health To Spend $3,100,000.00 To Occupy 3,794 Square Feet Of Space In Indianapolis Indiana.

Cardinal Health to spend $3,100,000.00 to occupy 3,794 square feet of space in Indianapolis Indiana. Cardinal Health to spend $3,100,000.00 to occupy 3,794 square feet of space in Indianapolis Indiana.Indianapolis, Indiana — According to state and local economic development sources, Cardinal Health plans to invest $3,100,000.00 to build out 3,794 square feet of new space in Indianapolis. The company plans to occupy the new space at 7736 Zionsville Rd in Indianapolis, on or about September 1, 2023. According to the company website Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for healthcare facilities. With operations in more than 30 countries and approximately 44,000 employees globally, Cardinal Health is essential to care. We are navigating the complexities of healthcare and providing scaled solutions to help our customers thrive in a changing world

GlobeNewswire
Jul 26th, 2022
RxLive Raises $5 Million Series A to Deliver Population Health Telepharmacy Solutions for At-Risk Patients

Digital Health Startup Is Tackling Medication Mismanagement, a $500 Billion Problem...